Patients with 3-vessel coronary artery disease and impaired ventricular function undergoing PCI with Impella 2.5 hemodynamic support have improved 90-day outcomes compared to intra-aortic balloon pump: A sub-study of the PROTECT II trial

Jason C. Kovacic, Annapoorna Kini, Subhash Banerjee, George Dangas, Joseph Massaro, Roxana Mehran, Jeffrey Popma, William W. O'Neill, Samin K. Sharma

Research output: Contribution to journalArticlepeer-review

32 Scopus citations

Fingerprint

Dive into the research topics of 'Patients with 3-vessel coronary artery disease and impaired ventricular function undergoing PCI with Impella 2.5 hemodynamic support have improved 90-day outcomes compared to intra-aortic balloon pump: A sub-study of the PROTECT II trial'. Together they form a unique fingerprint.

Medicine & Life Sciences